Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter

Neuroscience

Volumn 244, Issue , 2013, Pages 113-121

  Yatomi, Y ^a   Tanaka, R ^a   Shimura, H ^b   Miyamoto, N ^b   Yamashiro, K ^a   Takanashi, M ^a   Urabe, T ^b   Hattori, N ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Chronic cerebral hypoperfusion; EAAT1; EAAT2; EAAT3; White matter damage

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; GLUTATHIONE TRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; BRAIN REGION; CELLULAR DISTRIBUTION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEUROMODULATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; UPREGULATION; WHITE MATTER; WHITE MATTER INJURY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CHRONIC DISEASE; CORPUS CALLOSUM; DEMYELINATING DISEASES; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACID TRANSPORTER 3; FEMALE; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; MALE; NERVE FIBERS, MYELINATED; NEURONS; OLIGODENDROGLIA; RATS; UP-REGULATION;

EID: 84877800895     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.04.018     Document Type: Article

References (38)

1. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
2. Arranz A.M., Gottlieb M., Perez-Cerda F., Matute C. Increased expression of glutamate transporters in subcortical white matter after transient focal cerebral ischemia. Neurobiol Dis 2010, 37:156-165.
3. Back S.A., Craig A., Kayton R.J., Luo N.L., Meshul C.K., Allcock N., Fern R. Hypoxia-ischemia preferentially triggers glutamate depletion from oligodendroglia and axons in perinatal cerebral white matter. J Cereb Blood Flow Metab 2007, 27:334-347.
4. Camacho A., Massieu L. Role of glutamate transporters in the clearance and release of glutamate during ischemia and its relation to neuronal death. Arch Med Res 2006, 37:11-18.
5. Chida Y., Kokubo Y., Sato S., Kuge A., Takemura S., Kondo R., Kayama T. The alterations of oligodendrocyte, myelin in corpus callosum, and cognitive dysfunction following chronic cerebral ischemia in rats. Brain Res 2011, 1414:22-31.
6. Choi D.W. Excitotoxic cell death. J Neurobiol 1992, 23:1261-1276.
7. Chu K., Lee S.T., Sinn D.I., Ko S.Y., Kim E.H., Kim J.M., Kim S.J., Park D.K., Jung K.H., Song E.C., Lee S.K., Kim M., Roh J.K. Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 2007, 38:177-182.
8. Cimarosti H., Jones N.M., O'Shea R.D., Pow D.V., Salbego C., Beart P.M. Hypoxic preconditioning in neonatal rat brain involves regulation of excitatory amino acid transporter 2 and estrogen receptor alpha. Neurosci Lett 2005, 385:52-57.
9. Danbolt N.C., Chaudhry F.A., Dehnes Y., Lehre K.P., Levy L.M., Ullensvang K., Storm-Mathisen J. Properties and localization of glutamate transporters. Prog Brain Res 1998, 116:23-43.
10. Desilva T.M., Billiards S.S., Borenstein N.S., Trachtenberg F.L., Volpe J.J., Kinney H.C., Rosenberg P.A. Glutamate transporter EAAT2 expression is up-regulated in reactive astrocytes in human periventricular leukomalacia. J Comp Neurol 2008, 508:238-248.
11. Francis P.T. The interplay of neurotransmitters in Alzheimer's disease. CNS Spectr 2005, 10:6-9.
12. Gottlieb M., Domercq M., Matute C. Altered expression of the glutamate transporter EAAC1 in neurons and immature oligodendrocytes after transient forebrain ischemia. J Cereb Blood Flow Metab 2000, 20:678-687.
13. Guo H., Lai L., Butchbach M.E., Stockinger M.P., Shan X., Bishop G.A., Lin C.L. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum mol genet 2003, 12:2519-2532.
14. Harada H., Wang Y., Mishima Y., Uehara N., Makaya T., Kano T. A novel method of detecting rCBF with laser-Doppler flowmetry without cranial window through the skull for a MCAO rat model. Brain Res Brain Res Protoc 2005, 14:165-170.
15. Harvey B.K., Airavaara M., Hinzman J., Wires E.M., Chiocco M.J., Howard D.B., Shen H., Gerhardt G., Hoffer B.J., Wang Y. Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke. PloS one 2011, 6:e22135.
16. Jacob C.P., Koutsilieri E., Bartl J., Neuen-Jacob E., Arzberger T., Zander N., Ravid R., Roggendorf W., Riederer P., Grunblatt E. Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. J Alzheimers dis 2007, 11:97-116.
17. Kanai Y., Hediger M.A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 1992, 360:467-471.
18. Karadottir R., Attwell D. Neurotransmitter receptors in the life and death of oligodendrocytes. Neuroscience 2007, 145:1426-1438.
19. Kato H., Kogure K. Biochemical and molecular characteristics of the brain with developing cerebral infarction. Cell Mol Neurobiol 1999, 19:93-108.
20. Kim K., Lee S.G., Kegelman T.P., Su Z.Z., Das S.K., Dash R., Dasgupta S., Barral P.M., Hedvat M., Diaz P., Reed J.C., Stebbins J.L., Pellecchia M., Sarkar D., Fisher P.B. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 2011, 226:2484-2493.
21. Kobayashi K., Hayashi M., Nakano H., Fukutani Y., Sasaki K., Shimazaki M., Koshino Y. Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Neuropathol Appl Neurobiol 2002, 28:238-251.
22. Lee S.G., Su Z.Z., Emdad L., Gupta P., Sarkar D., Borjabad A., Volsky D.J., Fisher P.B. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem 2008, 283:13116-13123.
23. Masliah E., Alford M., DeTeresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 1996, 40:759-766.
24. Miyamoto N., Tanaka R., Shimura H., Watanabe T., Mori H., Onodera M., Mochizuki H., Hattori N., Urabe T. Phosphodiesterase III inhibition promotes differentiation and survival of oligodendrocyte progenitors and enhances regeneration of ischemic white matter lesions in the adult mammalian brain. J Cereb Blood Flow Metab 2010, 30:299-310.
25. Mookherjee P., Green P.S., Watson G.S., Marques M.A., Tanaka K., Meeker K.D., Meabon J.S., Li N., Zhu P., Olson V.G., Cook D.G. GLT-1 loss accelerates cognitive deficit onset in an Alzheimer's disease animal model. J Alzheimers dis 2011, 26:447-455.
26. Pines G., Danbolt N.C., Bjoras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B.I. Cloning and expression of a rat brain l-glutamate transporter. Nature 1992, 360:464-467.
27. Rao V.L., Bowen K.K., Dempsey R.J. Transient focal cerebral ischemia down-regulates glutamate transporters GLT-1 and EAAC1 expression in rat brain. Neurochem Res 2001, 26:497-502.
28. Rao V.L., Dogan A., Todd K.G., Bowen K.K., Kim B.T., Rothstein J.D., Dempsey R.J. Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J Neurosci 2001, 21:1876-1883.
29. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Dykes Hoberg M., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z.Z., Gupta P., Fisher P.B. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005, 433:73-77.
30. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995, 38:73-84.
31. Sasaki K., Shimura H., Itaya M., Tanaka R., Mori H., Mizuno Y., Kosik K.S., Tanaka S., Hattori N. Excitatory amino acid transporter 2 associates with phosphorylated tau and is localized in neurofibrillary tangles of tauopathic brains. FEBS Lett 2009, 583:2194-2200.
32. Tekkok S.B., Ye Z., Ransom B.R. Excitotoxic mechanisms of ischemic injury in myelinated white matter. J Cereb Blood Flow Metab 2007, 27:1540-1552.
33. Thomas A.J., Perry R., Barber R., Kalaria R.N., O'Brien J.T. Pathologies and pathological mechanisms for white matter hyperintensities in depression. Ann N Y Acad Sci 2002, 977:333-339.
34. Tomimoto H., Ihara M., Wakita H., Ohtani R., Lin J.X., Akiguchi I., Kinoshita M., Shibasaki H. Chronic cerebral hypoperfusion induces white matter lesions and loss of oligodendroglia with DNA fragmentation in the rat. Acta Neuropathol 2003, 106:527-534.
35. Wakita H., Tomimoto H., Akiguchi I., Matsuo A., Lin J.X., Ihara M., McGeer P.L. Axonal damage and demyelination in the white matter after chronic cerebral hypoperfusion in the rat. Brain Res 2002, 924:63-70.
36. Weller M.L., Stone I.M., Goss A., Rau T., Rova C., Poulsen D.J. Selective overexpression of excitatory amino acid transporter 2 (EAAT2) in astrocytes enhances neuroprotection from moderate but not severe hypoxia-ischemia. Neuroscience 2008, 155:1204-1211.
37. Werner P., Pitt D., Raine C.S. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 2001, 50:169-180.
38. Yamada T., Kawahara K., Kosugi T., Tanaka M. Nitric oxide produced during sublethal ischemia is crucial for the preconditioning-induced down-regulation of glutamate transporter GLT-1 in neuron/astrocyte co-cultures. Neurochem Res 2006, 31:49-56.